3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
13
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Mantle-Cell
7
Lymphoma, Non-Hodgkin
5
Waldenstrom Macroglobulinemia
4
Neoplasms
3
Lymphoma
3
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Hairy Cell
2
Burkitt Lymphoma
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Central Nervous System Lymphoma (PCNSL)
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic
1
Leukemia, Myeloid, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Anemia
1
Interventions
piperine
1
Curcumin
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Monoclonal Gammopathy of Undetermined Significance
×
ibrutinib
×
30 days
×
Clear all
No trials found.